60 Second Interview with Dr Yijia Li
Much is made of the opportunities becoming available to cord blood banks to diversify - for example, by sourcing new revenue streams. How is this picture evolving within China?
What sort of partnerships or business opportunities are Chinese cord blood banks seeking on an international basis?
What is your outlook on the global cord blood and tissue sector over the coming 5-10 years? How and where specifically do you expect the sector to flourish?
Dr Yijia Li will be at Phacilitate Leaders Forum 2018
Dr Yijia Li will be speaking at Cord Blood and Perinatal Stem Cells Conference on the Global Cord Blood & Tissue Bank Roundtable, taking place on Wednesday, January 24 at 02:15pm.
For the opportunity to meet Dr. Li and ask some of your own questions, book your place now.
About the cord blood industry in China
China has a fascinating and unique market for cord blood banking. The Chinese government issues one cord blood banking license per province, and the licensed company must function as both a public (donation-based) and private (for-profit) bank. The for-profit division funds the company’s donation-based public division, because no government support is received for this purpose.
You can read more about China's cord blood bank sector here, or you can purchase the 'Complete 2017-18 Global Cord Blood Banking Industry Report' by BioInformant.
About Dr Yijia Li